Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04212468

Home Blood Pressure Monitoring Registration Study in the Elderly(HOME Study)

China is entering an aging society. As the number of elderly population continues to increase, the elderly are facing many social problems that deserve the attention of all sectors of society. Hypertension is one of the common diseases in the elderly population. Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. Home blood pressure monitoring is simple, not only can find hypertension, but also can guide the treatment of patients with hypertension. The purpose of the study is to investigate the association between home blood pressure and adverse outcomes in community elderly population.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Blood Pressure

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Feng Yingqing, Guangzhou, Guangdong, China

Loading trial locations.

About this study

Study population includes subjects who living in community, of any race or ethnicity, 65 or older years of age, and have provided written informed consent to provide home blood pressure monitoring at one or more study visits.

Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of a composite of major adverse cardiovascular events will be investigated during follow-up.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

•≥65 years old

  • Signed informed consent
  • Life expectancy is greater than 1 year

Exclusion criteria

  • <65 years old
  • Unsigned informed consent

Treatment and study plan

No intervention

Other

no intervention

Primary outcomes

  1. All-Cause Mortality

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year

    All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention.

  2. Cardiovascular Mortality

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year

    Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke).

Secondary outcomes

  1. Secondary outcomes of cardiovascular diseases

    Time frame: Through study completion, an average of 1 years

    The number of and the incidence rate of cardiovascular diseases.

  2. Secondary outcomes of cerebrovascular diseases

    Time frame: Through study completion, an average of 1 years

    The incidence rate of cerebrovascular diseases.

  3. Secondary outcomes of kidney

    Time frame: Through study completion, an average of 1 years

    The incidence rate of renal injure and end-stage renal disease

  4. Secondary outcomes of hypertension

    Time frame: Through study completion, an average of 1 years

    The incidence rate of hypertension

  5. Secondary outcomes of diabetes

    Time frame: Through study completion, an average of 1 years

    The incidence rate of diabetes

Other outcomes

  1. Number of participants with reported hospitalization due to other diseases

    Time frame: From date of inclusion until the date of first event, assessed up to 1 year

    The incidence rate of tumor, fracture, cataract etc.

Study contacts

Contact information is provided by the study sponsor or research team.

Feng Ying-qing, PhD

CONTACT

[email protected]

+862083827812

Sponsors and collaborators

Lead sponsor

Guangdong Provincial People's Hospital

Other

Registry information

Official study title

Home Blood Pressure Registration Study on Community Elderly Population(HOME Study)

Important dates

Study start
2020
Primary completion
2024
Study completion
2050
First posted
Dec 27, 2019
Registry last updated
Jan 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.